Document ID: chunk:federal_register_of_legislation:F2018L01673:body:0:p1
Version: federal_register_of_legislation:F2018L01673
Segment Type: other
Provision Reference: 
Character Range: 0–3517

PB 107 of 2018 (No. 11)

National Health (Highly specialised drugs program) Amendment (Approval of certain hospital authorities) Special Arrangement 2018

National Health Act 1953
___________________________________________________________________________

I, JULIANNE QUAINE, Assistant Secretary, Pharmacy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 100(2) of the National Health Act 1953.

Dated 4 December 2018

JULIANNE QUAINE
Assistant Secretary
Pharmacy Branch
Technology Assessment and Access Division
Department of Health
___________________________________________________________________________

Contents
1 Name
2 Commencement
3 Authority
4 Schedules
Schedule 1  Amendments
Schedule 2  Transitional provisions

___________________________________________________________________________

1 Name

       (1)           This Instrument is the National Health (Highly Specialised drugs program) Amendment (Approval of certain hospital authorities) Special Arrangement 2018.

       (2)           This Instrument may also be cited as PB 107 of 2018 (No. 11).

2 Commencement

 (1) Each provision of this instrument specified in column 1 of the table commences,                             or is taken to have commenced, in accordance with column 2 of the table. Any                             other               statement in column 2 has effect according to its terms.

Commencement information
Column 1                   Column 2          Column 3
Provisions                 Commencement      Date/Details
1.  The whole instrument   21 December 2018

    (2) Any information in column 3 of the table is not part of this instrument.  Information may be inserted in this column, or information in it may be edited, in               any published version of this instrument.

3 Authority

    This instrument is made under section 100 of the National Health Act 1953.

4 Schedules

         Each instrument that is specified in a Schedule to this instrument is amended or  repealed as set out in the applicable items in the Schedule concerned, and any other               item in a Schedule to this instrument has effect according to its terms.

Schedule 1  Amendments

National Health (Highly specialised drugs program) Special Arrangement 2010

1 Section 4 (subparagraph (a)(ii) of the definition of approved hospital authority)

 Omit 'Chief Executive Medicare', substitute 'Secretary'.

2 Section 4 (definition of Regulations)

    Omit 'National Health (Pharmaceutical Benefits) Regulations 1960', substitute 'National Health (Pharmaceutical Benefit) Regulations 2017'.

3 Section 19 (including heading)

 Repeal the section, substitute:

    19 Application of section 51 of the Regulations

              Section 51 of the Regulations does not apply to the supply of HSD pharmaceutical benefits.

4 Paragraph 21(a)

    Omit 'regulation 19', substitute 'section 40'.

5 Paragraph 21(b)

    Omit 'regulation 19AA', substitute 'section 41'.

6 Section 21 (note)

    Omit 'Regulation 13', substitute 'section 30'.

7 Section 23

    Omit 'regulation 19', substitute 'section 40'.

8 Section 26 (including heading)

    Repeal the section, substitute:

    26  Application of section 30 of the Regulations in relation to CAR drugs

    Section 30 of the Regulations does not apply in relation to a prescription for an HSD pharmaceutical benefit that has a CAR drug